Skip to main content

Targeting leukaemia specific regulatory elements for the treatment of intermediate and high risk patients

Project Member(s): Beck, D.

Funding or Partner Organisation: Gilead Sciences Pty Ltd (Gilead Sciences International Research Scholars Program Hematology / Oncology)
Gilead Sciences Pty Ltd (Gilead Sciences International Research Scholars Program Hematology / Oncology)

Start year: 2017

Publications:

Beck, D, Thoms, JAI, Palu, C, Herold, T, Shah, A, Olivier, J, Boelen, L, Huang, Y, Chacon, D, Brown, A, Babic, M, Hahn, C, Perugini, M, Zhou, X, Huntly, BJ, Schwarzer, A, Klusmann, J-H, Berdel, WE, Wörmann, B, Büchner, T, Hiddemann, W, Bohlander, SK, To, LB, Scott, HS, Lewis, ID, D'Andrea, RJ, Wong, JWH & Pimanda, JE 2018, 'A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.', Leukemia, vol. 32, no. 2, pp. 263-272.
View/Download from: UTS OPUS or Publisher's site

Jing, D, Huang, Y, Liu, X, Sia, KCS, Zhang, JC, Tai, X, Wang, M, Toscan, CE, McCalmont, H, Evans, K, Mayoh, C, Poulos, RC, Span, M, Mi, J, Zhang, C, Wong, JWH, Beck, D, Pimanda, JE & Lock, RB 2018, 'Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia', CANCER CELL, vol. 34, no. 6, pp. 906-+.
View/Download from: UTS OPUS or Publisher's site

Liu, K, Beck, D, Thoms, JAI, Liu, L, Zhao, W, Pimanda, JE & Zhou, X 2017, 'Annotating function to differentially expressed LincRNAs in myelodysplastic syndrome using a network-based method', Bioinformatics (Oxford, England), vol. 33, no. 17, pp. 2622-2630.
View/Download from: UTS OPUS or Publisher's site

FOR Codes: Haematological Tumours, Blood Disorders